- Like many charities, Allergy UK, whose slogan is “supporting people living with allergy”, owns a trading subsidiary: Allergy Research Limited (“ARL”).
- ARL, which donates all profits to the charity, makes money via its product endorsement schemes, among other activities.
- Under the “Seal of Approval” scheme, for example, third party businesses pay ARL to arrange “independent laboratory testing” of their products, in order to identify those (products) “proven to reduce or remove allergens from the indoor environment”. Successful products are permitted to use Allergy UK’s “Seal of Approval” logo for a year, before renewal is required (screen shot in Figure 1).
- There are at least two problems with the charity endorsing products.
- First, being paid, Allergy UK’s endorsement isn’t a disinterested one. This creates a possible conflict of interest for the charity, which in turn risks undermining the independence and credibility of its endorsements. What’s more, ARL is the charity’s main funding source.
- Second, ARL is opaque. The accounts filed at Companies House reveal nothing about how the trading subsidiary actually carries out its activities. Allergy UK’s accounts, too, omit to provide details. How many applications fail, if any? Clarity and transparency around ARL’s product endorsement schemes would only enhance trust and confidence in the approval process. Or is it merely a rubber-stamping exercise?
- Allergy UK didn’t respond to requests for comment.